Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Salek F et al. | 2021 | intact cell/cell culture | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 2.5 mT |
Koziorowska A et al. | 2017 | intact cell/cell culture, 143B (human osteosarcoma cell line), BJ (human fibroblast cell line) | 50/60 Hz, magnetic field | 2–6 mT |
Sztafrowski D et al. | 2023 | intact cell/cell culture, <i>Candida albicans</i> (strains CAF2-1 and CAF4-2) | 50/60 Hz, magnetic field, co-exposure, also other exposures without EMF | - |
Shang GM et al. | 2004 | intact cell/cell culture, <i>Taxus chinensis</i> var. <i>mairei</i> | static magnetic field, magnetic field, 50/60 Hz | - |
Dehghani-Soltani S et al. | 2021 | intact cell/cell culture, A172 (human glioblastoma cells) and T98 cell line | magnetic field, 50/60 Hz, signals/pulses, co-exposure, also other exposures without EMF | 7 mT |
Amirinejad M et al. | 2024 | intact cell/cell culture, A172 and T98G (human glioblastoma cells) cell lines | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Baharara J et al. | 2016 | intact cell/cell culture, A2780 cells (cisplatin-resistant human ovarian adenocarcinoma cells) | magnetic field, 50/60 Hz, co-exposure | 20 mT |
Panjali Z et al. | 2022 | intact cell/cell culture, A549 (human lung cancer cell line) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Kwee S et al. | 1995 | intact cell/cell culture, AMA cells (human epithelial amnion cells) and K14 cells (human skin fibroblasts) | magnetic field, low frequency, 50/60 Hz | 25–180 µT |
Kim YM et al. | 2016 | intact cell/cell culture, B16F10 (murine melanoma cells) | magnetic field, low frequency, signals/pulses, 50/60 Hz | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.